AWM Investment Company’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-55,699
Closed -$2.95M 98
2016
Q1
$2.95M Buy
55,699
+8,881
+19% +$519K 0.62% 48
2015
Q4
$3.6M Sell
46,818
-68,200
-59% -$3.86M 0.71% 39
2015
Q3
$4.73M Buy
115,018
+10,000
+10% +$612K 0.92% 35
2015
Q2
$7.43M Buy
105,018
+35,000
+50% +$2.76M 1.05% 32
2015
Q1
$6.22M Sell
70,018
-109,982
-61% -$11.2M 0.86% 44
2014
Q4
$16M Buy
+180,000
New +$17M 2.18% 8

Other funds holding PCRX

AWM Investment Company's PCRX Position: Q2 2016 in Review

AWM Investment Company sold out of Pacira BioSciences (PCRX) in Q2 2016, closing a stake of 55,699 shares — an estimated $2.95M sold.

AWM Investment Company first reported a position in PCRX in Q4 2014 and held it in 6 quarters. The position peaked at $16M in Q4 2014. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

  • AWM Investment Company reported no remaining Pacira BioSciences position as of Q2 2016 after selling out during the quarter.
  • AWM Investment Company sold 55,699 Pacira BioSciences shares in Q2 2016, an estimated $2.95M.
  • AWM Investment Company first reported a position in Pacira BioSciences in Q4 2014 and held it in 6 quarters.
  • AWM Investment Company's Pacira BioSciences position peaked at $16M in Q4 2014.
  • 183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on AWM Investment Company's 13F filing for Q2 2016, filed 9 Aug 2016.